![Althea Stillman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Althea Stillman
Directeur/Bestuurslid bij Innervace, Inc.
Profiel
Althea Stillman is currently a Director at Innervace, Inc. Previously, she worked as a Director at CTx Operations, Inc. She holds a doctorate degree from Yale University and an undergraduate degree from the University of California, Berkeley.
Actieve functies van Althea Stillman
Bedrijven | Functie | Begin |
---|---|---|
Innervace, Inc.
![]() Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Althea Stillman
Bedrijven | Functie | Einde |
---|---|---|
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Directeur/Bestuurslid | - |
Opleiding van Althea Stillman
University of California, Berkeley | Undergraduate Degree |
Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Innervace, Inc.
![]() Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Health Technology |